Content
12/11/2024
Santa Cruz, CA USA
Capstan Medical
completed $110 million Series C Round funding. Investors include
Eclipse (lead), Gideon Strategic Partners, Intuitive Ventures, Yu Galaxy.
About
Founded in 2020, Capstan Medical is creating a new standard for minimally invasive, heart valve intervention. The company is developing a suite of next-generation heart valve implants and a first-of-its-kind catheter-based robotic delivery platform.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
